PLATFORM TECHNOLOGY TRANSFER, COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN CODEXIS, INC. AND GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED EFFECTIVE AS OFPlatform Technology Transfer, Collaboration and License Agreement • August 5th, 2022 • Codexis, Inc. • Industrial organic chemicals • Delaware
Contract Type FiledAugust 5th, 2022 Company Industry Jurisdiction
PLATFORM TECHNOLOGY TRANSFER, COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN CODEXIS, INC. AND GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED EFFECTIVE AS OF 10 July 2014Platform Technology Transfer, Collaboration and License Agreement • November 6th, 2014 • Codexis Inc • Industrial organic chemicals • Delaware
Contract Type FiledNovember 6th, 2014 Company Industry JurisdictionTHIS PLATFORM TECHNOLOGY TRANSFER, COLLABORATION AND LICENSE AGREEMENT (together with any exhibits attached hereto, this “Agreement”) is made and entered into as of 10 July 2014 (the “Effective Date”), by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, United States of America, (“Codexis”) and GlaxoSmithKline Intellectual Property Development Limited, an English company headquartered at 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom (“GSK”). Codexis and GSK are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”